Our previous study has disclosed that the neuroprotection of OM-MSCs against cerebral IRI was achieved partially through improving the expression and function of SPCA1 and reducing the edema and dissolution of the GA in neurons [21]. Here, ATP2C1 is linked to ocular melanoma.